Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

AMS vs BLCO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AMS
American Shared Hospital Services

Medical - Care Facilities

HealthcareAMEX • US
Market Cap$13M
5Y Perf.-13.5%
BLCO
Bausch + Lomb Corporation

Medical - Instruments & Supplies

HealthcareNYSE • CA
Market Cap$5.67B
5Y Perf.-6.5%

AMS vs BLCO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AMS logoAMS
BLCO logoBLCO
IndustryMedical - Care FacilitiesMedical - Instruments & Supplies
Market Cap$13M$5.67B
Revenue (TTM)$29M$5.21B
Net Income (TTM)$-2M$-219M
Gross Margin25.0%55.9%
Operating Margin-12.3%5.9%
Forward P/E6.1x20.1x
Total Debt$23M$5.37B
Cash & Equiv.$11M$383M

AMS vs BLCOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AMS
BLCO
StockMay 22May 26Return
American Shared Hos… (AMS)10086.5-13.5%
Bausch + Lomb Corpo… (BLCO)10093.5-6.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: AMS vs BLCO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AMS and BLCO are tied at the top with 3 categories each — the right choice depends on your priorities. Bausch + Lomb Corporation is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
AMS
American Shared Hospital Services
The Growth Play

AMS has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.

  • Rev growth 32.9%, EPS growth 245.9%, 3Y rev CAGR 17.1%
  • -4.7% 10Y total return vs BLCO's -20.5%
  • Lower volatility, beta -0.02, Low D/E 77.4%, current ratio 2.52x
Best for: growth exposure and long-term compounding
BLCO
Bausch + Lomb Corporation
The Quality Compounder

BLCO is the clearest fit if your priority is quality and momentum.

  • -4.2% margin vs AMS's -7.6%
  • +39.5% vs AMS's -27.4%
  • -1.6% ROA vs AMS's -3.8%, ROIC 1.2% vs -5.8%
Best for: quality and momentum
See the full category breakdown
CategoryWinnerWhy
GrowthAMS logoAMS32.9% revenue growth vs BLCO's 6.5%
ValueAMS logoAMSLower P/E (6.1x vs 20.1x)
Quality / MarginsBLCO logoBLCO-4.2% margin vs AMS's -7.6%
Stability / SafetyAMS logoAMSLower D/E ratio (77.4% vs 82.4%)
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)BLCO logoBLCO+39.5% vs AMS's -27.4%
Efficiency (ROA)BLCO logoBLCO-1.6% ROA vs AMS's -3.8%, ROIC 1.2% vs -5.8%

AMS vs BLCO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AMSAmerican Shared Hospital Services
FY 2024
Rental Income from Medical Services
55.1%$16M
Patient Income
44.3%$13M
Equipment Sales
0.5%$155,000
BLCOBausch + Lomb Corporation
FY 2025
Device Products
37.7%$1.9B
Over the Counter Products
36.0%$1.8B
Pharmaceutical Products
21.2%$1.1B
Branded and Other Generic Products
4.8%$243M
Other Revenues
0.4%$21M

AMS vs BLCO — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBLCOLAGGINGAMS

Income & Cash Flow (Last 12 Months)

BLCO leads this category, winning 6 of 6 comparable metrics.

BLCO is the larger business by revenue, generating $5.2B annually — 177.0x AMS's $29M. Profitability is closely matched — net margins range from -4.2% (BLCO) to -7.6% (AMS). On growth, BLCO holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAMS logoAMSAmerican Shared H…BLCO logoBLCOBausch + Lomb Cor…
RevenueTrailing 12 months$29M$5.2B
EBITDAEarnings before interest/tax$2M$724M
Net IncomeAfter-tax profit-$2M-$219M
Free Cash FlowCash after capex-$10M$4M
Gross MarginGross profit ÷ Revenue+25.0%+55.9%
Operating MarginEBIT ÷ Revenue-12.3%+5.9%
Net MarginNet income ÷ Revenue-7.6%-4.2%
FCF MarginFCF ÷ Revenue-34.7%+0.1%
Rev. Growth (YoY)Latest quarter vs prior year+2.5%+9.4%
EPS Growth (YoY)Latest quarter vs prior year-56.7%+66.7%
BLCO leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

AMS leads this category, winning 3 of 4 comparable metrics.

On an enterprise value basis, AMS's 7.5x EV/EBITDA is more attractive than BLCO's 17.5x.

MetricAMS logoAMSAmerican Shared H…BLCO logoBLCOBausch + Lomb Cor…
Market CapShares × price$13M$5.7B
Enterprise ValueMkt cap + debt − cash$25M$10.7B
Trailing P/EPrice ÷ TTM EPS6.09x-15.59x
Forward P/EPrice ÷ next-FY EPS est.20.10x
PEG RatioP/E ÷ EPS growth rate0.93x
EV / EBITDAEnterprise value multiple7.51x17.50x
Price / SalesMarket cap ÷ Revenue0.46x1.11x
Price / BookPrice ÷ Book value/share0.45x0.86x
Price / FCFMarket cap ÷ FCF
AMS leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

BLCO leads this category, winning 5 of 9 comparable metrics.

BLCO delivers a -3.4% return on equity — every $100 of shareholder capital generates $-3 in annual profit, vs $-8 for AMS. AMS carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLCO's 0.82x. On the Piotroski fundamental quality scale (0–9), AMS scores 5/9 vs BLCO's 3/9, reflecting solid financial health.

MetricAMS logoAMSAmerican Shared H…BLCO logoBLCOBausch + Lomb Cor…
ROE (TTM)Return on equity-7.9%-3.4%
ROA (TTM)Return on assets-3.8%-1.6%
ROICReturn on invested capital-5.8%+1.2%
ROCEReturn on capital employed-6.4%+1.6%
Piotroski ScoreFundamental quality 0–953
Debt / EquityFinancial leverage0.77x0.82x
Net DebtTotal debt minus cash$12M$5.0B
Cash & Equiv.Liquid assets$11M$383M
Total DebtShort + long-term debt$23M$5.4B
Interest CoverageEBIT ÷ Interest expense-1.35x0.71x
BLCO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BLCO leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in BLCO five years ago would be worth $7,950 today (with dividends reinvested), compared to $5,894 for AMS. Over the past 12 months, BLCO leads with a +39.5% total return vs AMS's -27.4%. The 3-year compound annual growth rate (CAGR) favors BLCO at -4.5% vs AMS's -10.4% — a key indicator of consistent wealth creation.

MetricAMS logoAMSAmerican Shared H…BLCO logoBLCOBausch + Lomb Cor…
YTD ReturnYear-to-date-4.3%-4.1%
1-Year ReturnPast 12 months-27.4%+39.5%
3-Year ReturnCumulative with dividends-28.0%-13.0%
5-Year ReturnCumulative with dividends-41.1%-20.5%
10-Year ReturnCumulative with dividends-4.7%-20.5%
CAGR (3Y)Annualised 3-year return-10.4%-4.5%
BLCO leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AMS and BLCO each lead in 1 of 2 comparable metrics.

AMS is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than BLCO's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLCO currently trades 84.0% from its 52-week high vs AMS's 64.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAMS logoAMSAmerican Shared H…BLCO logoBLCOBausch + Lomb Cor…
Beta (5Y)Sensitivity to S&P 500-0.02x1.39x
52-Week HighHighest price in past year$3.11$18.92
52-Week LowLowest price in past year$1.25$10.85
% of 52W HighCurrent price vs 52-week peak+64.6%+84.0%
RSI (14)Momentum oscillator 0–10063.846.9
Avg Volume (50D)Average daily shares traded138K412K
Evenly matched — AMS and BLCO each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricAMS logoAMSAmerican Shared H…BLCO logoBLCOBausch + Lomb Cor…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$19.00
# AnalystsCovering analysts16
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

BLCO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AMS leads in 1 (Valuation Metrics). 1 tied.

Best OverallBausch + Lomb Corporation (BLCO)Leads 3 of 6 categories
Loading custom metrics...

AMS vs BLCO: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is AMS or BLCO a better buy right now?

For growth investors, American Shared Hospital Services (AMS) is the stronger pick with 32.

9% revenue growth year-over-year, versus 6. 5% for Bausch + Lomb Corporation (BLCO). American Shared Hospital Services (AMS) offers the better valuation at 6. 1x trailing P/E, making it the more compelling value choice. Analysts rate Bausch + Lomb Corporation (BLCO) a "Hold" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — AMS or BLCO?

Over the past 5 years, Bausch + Lomb Corporation (BLCO) delivered a total return of -20.

5%, compared to -41. 1% for American Shared Hospital Services (AMS). Over 10 years, the gap is even starker: AMS returned -4. 7% versus BLCO's -20. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — AMS or BLCO?

By beta (market sensitivity over 5 years), American Shared Hospital Services (AMS) is the lower-risk stock at -0.

02β versus Bausch + Lomb Corporation's 1. 39β — meaning BLCO is approximately -8976% more volatile than AMS relative to the S&P 500. On balance sheet safety, American Shared Hospital Services (AMS) carries a lower debt/equity ratio of 77% versus 82% for Bausch + Lomb Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — AMS or BLCO?

By revenue growth (latest reported year), American Shared Hospital Services (AMS) is pulling ahead at 32.

9% versus 6. 5% for Bausch + Lomb Corporation (BLCO). On earnings-per-share growth, the picture is similar: American Shared Hospital Services grew EPS 245. 9% year-over-year, compared to -13. 3% for Bausch + Lomb Corporation. Over a 3-year CAGR, AMS leads at 17. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — AMS or BLCO?

American Shared Hospital Services (AMS) is the more profitable company, earning 7.

7% net margin versus -7. 1% for Bausch + Lomb Corporation — meaning it keeps 7. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BLCO leads at 3. 7% versus -9. 9% for AMS. At the gross margin level — before operating expenses — BLCO leads at 54. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — AMS or BLCO?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is AMS or BLCO better for a retirement portfolio?

For long-horizon retirement investors, American Shared Hospital Services (AMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

02)). Both have compounded well over 10 years (AMS: -4. 7%, BLCO: -20. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between AMS and BLCO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AMS is a small-cap high-growth stock; BLCO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

AMS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 14%
Run This Screen
Stocks Like

BLCO

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AMS and BLCO on the metrics below

Revenue Growth>
%
(AMS: 2.5% · BLCO: 9.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.